{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:38:54Z","timestamp":1781044734148,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["SBAG-113S256"],"award-info":[{"award-number":["SBAG-113S256"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005378","name":"Hacettepe University","doi-asserted-by":"publisher","award":["TDK-2017-14607"],"award-info":[{"award-number":["TDK-2017-14607"]}],"id":[{"id":"10.13039\/501100005378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.biochi.2017.12.004","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T18:02:23Z","timestamp":1513274543000},"page":"105-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease"],"prefix":"10.1016","volume":"146","author":[{"given":"Melike","family":"Yuksel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevser","family":"Biberoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seda","family":"Onder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Gonca","family":"Akbulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozden","family":"Tacal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2017.12.004_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4103\/0973-029X.99081","article-title":"Toluidine blue: a review of its chemistry and clinical utility","volume":"16","author":"Sridharan","year":"2012","journal-title":"J.\u00a0Oral Maxillofac. Pathol."},{"key":"10.1016\/j.biochi.2017.12.004_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00418-001-0343-5","article-title":"Toluidine blue-O staining of prion protein deposits","volume":"116","author":"Sanchez","year":"2001","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.biochi.2017.12.004_bib3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/odi.12358","article-title":"Toluidine blue aids in detection of dysplasia and carcinoma in suspicious oral lesions","volume":"21","author":"Chainani-Wu","year":"2015","journal-title":"Oral Dis."},{"key":"10.1016\/j.biochi.2017.12.004_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/lsm.1105","article-title":"Comparison of the methylene blue and toluidine blue photobactericidal efficacy against gram-positive and gram-negative microorganisms","volume":"29","author":"Usacheva","year":"2001","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.biochi.2017.12.004_bib5","first-page":"329","article-title":"Pharmacokinetics and toxicity of tolonium chloride in sheep","volume":"38","author":"Cudd","year":"1996","journal-title":"Vet. Hum. Toxicol."},{"key":"10.1016\/j.biochi.2017.12.004_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00562507","article-title":"Comparative studies on the effects of toluidine blue and methylene blue on the reduction of ferrihaemoglobin in man and dog","volume":"4","author":"Kiese","year":"1972","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.biochi.2017.12.004_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1574-695X.1997.tb01074.x","article-title":"A\u00a0study of photobactericidal activity in the phenothiazinium series","volume":"19","author":"Wainwright","year":"1997","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.biochi.2017.12.004_bib8","doi-asserted-by":"crossref","first-page":"H137","DOI":"10.1152\/ajpheart.2000.278.1.H137","article-title":"Toluidine blue O and methylene blue as endothelial redox probes in the intact lung","volume":"278","author":"Audi","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biochi.2017.12.004_bib9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.freeradbiomed.2007.03.035","article-title":"NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis","volume":"43","author":"Wondrak","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biochi.2017.12.004_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1039\/b818585a","article-title":"Differential photodynamic response of cultured cells to methylene blue and toluidine blue: role of dark redox processes","volume":"8","author":"Blazquez-Castro","year":"2009","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.biochi.2017.12.004_bib11","series-title":"Implications of the Blood-brain Barrier and its Manipulation","first-page":"29","article-title":"History of the blood-brain barrier concept","author":"Davson","year":"1989"},{"key":"10.1016\/j.biochi.2017.12.004_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.abb.2016.06.005","article-title":"Toluidine blue O is a potent inhibitor of human cholinesterases","volume":"604","author":"Biberoglu","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biochi.2017.12.004_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0011-393X(03)00059-6","article-title":"Cholinesterase inhibitors for the treatment of Alzheimer's disease: getting on and staying on","volume":"64","author":"Grossberg","year":"2003","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.biochi.2017.12.004_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer's disease: a review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.biochi.2017.12.004_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0166-2236(98)01361-7","article-title":"Acetylcholine in mind: a neurotransmitter correlate of consciousness?","volume":"22","author":"Perry","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biochi.2017.12.004_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer's disease","volume":"34","author":"O'Brien","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.biochi.2017.12.004_bib17","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1755-5949.2010.00177.x","article-title":"The role of tau in Alzheimer's disease and related disorders","volume":"17","author":"Medeiros","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biochi.2017.12.004_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","article-title":"An overview of APP processing enzymes and products","volume":"12","author":"Chow","year":"2010","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.biochi.2017.12.004_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer's disease and the \u03b2-amyloid peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.biochi.2017.12.004_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.00024.2003","article-title":"Role of tau protein in both physiological and pathological conditions","volume":"84","author":"Avila","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biochi.2017.12.004_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-3-7091-6139-5_17","article-title":"Long-term stabilizing effect of cholinesterase inhibitors in the therapy of Alzheimer'disease","author":"Giacobini","year":"2002","journal-title":"J.\u00a0Neural. Transm. Suppl."},{"key":"10.1016\/j.biochi.2017.12.004_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00023210-200115020-00001","article-title":"Do cholinesterase inhibitors have disease-modifying effects in Alzheimer's disease?","volume":"15","author":"Giacobini","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biochi.2017.12.004_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.phrs.2003.12.027","article-title":"Acetylcholinesterase inhibitors: novel activities of old molecules","volume":"50","author":"Racchi","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biochi.2017.12.004_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021954","article-title":"Rivastigmine lowers A\u03b2 and increases sAPP\u03b1 levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neurons","volume":"6","author":"Bailey","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biochi.2017.12.004_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1134\/S181971241303015X","article-title":"Effects of rivastigmine on secreted amyloid precursor protein and beta-amyloid secretion in neuroblastoma SK-N-SH cells","volume":"7","author":"Yang","year":"2013","journal-title":"Neurochem. J."},{"key":"10.1016\/j.biochi.2017.12.004_bib26","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.exger.2010.06.008","article-title":"Effects of galantamine on \u03b2-amyloid release and beta-site cleaving enzyme 1 expression in differentiated human neuroblastoma SH-SY5Y cells","volume":"45","author":"Li","year":"2010","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.biochi.2017.12.004_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.brainres.2009.09.097","article-title":"Effects of donepezil on amyloid-\u03b2 and synapse density in the Tg2576 mouse model of Alzheimer's disease","volume":"1303","author":"Dong","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.biochi.2017.12.004_bib28","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/acschemneuro.5b00040","article-title":"Age-related decline in brain and hepatic clearance of amyloid-beta is rectified by the cholinesterase inhibitors donepezil and rivastigmine in rats","volume":"6","author":"Mohamed","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biochi.2017.12.004_bib29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biochi.2017.04.012","article-title":"Effects of phenothiazine-structured compounds on APP processing in Alzheimer's disease cellular model","volume":"138","author":"Yuksel","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.biochi.2017.12.004_bib30","doi-asserted-by":"crossref","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","article-title":"Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines","volume":"93","author":"Wischik","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2017.12.004_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048279","article-title":"Neuroprotective actions of methylene blue and its derivatives","volume":"7","author":"Poteet","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biochi.2017.12.004_bib32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2007.06.013","article-title":"Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice","volume":"28","author":"Clinton","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biochi.2017.12.004_bib33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2008.03.079","article-title":"Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model","volume":"1216","author":"Hirata-Fukae","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.biochi.2017.12.004_bib34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A\u03b2 and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.biochi.2017.12.004_bib35","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","article-title":"Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice","volume":"45","author":"Billings","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.biochi.2017.12.004_bib36","first-page":"96","article-title":"A\u00a0study of the acute and chronic toxicity of toluidine blue and related phenazine and thiazine dyes","volume":"9","author":"Haley","year":"1951","journal-title":"Stanford Med. Bull."},{"key":"10.1016\/j.biochi.2017.12.004_bib37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00000658-196906000-00001","article-title":"Toluidine blue in identification of parathyroid glands at operation","volume":"169","author":"Yeager","year":"1969","journal-title":"Ann. Surg."},{"issue":"3.33","key":"10.1016\/j.biochi.2017.12.004_bib38","first-page":"1","article-title":"Isolation and biochemical characterization of amyloid plaques and paired helical filaments","volume":"44","author":"Rostagno","year":"2009","journal-title":"Curr. Protoc. Cell Biol."},{"key":"10.1016\/j.biochi.2017.12.004_bib39","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1038\/emboj.2010.211","article-title":"Neurotoxicity of Alzheimer's disease A\u03b2 peptides is induced by small changes in the A\u03b242 to A\u03b240 ratio","volume":"29","author":"Kuperstein","year":"2010","journal-title":"Embo J."},{"key":"10.1016\/j.biochi.2017.12.004_bib40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.biochi.2017.12.004_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S1461145705005833","article-title":"Targeting acetylcholinesterase and butyrylcholinesterase in dementia","volume":"9","author":"Lane","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.biochi.2017.12.004_bib42","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2353\/ajpath.2010.090452","article-title":"Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice","volume":"176","author":"Martinez-Coria","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biochi.2017.12.004_bib43","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1074\/jbc.M507892200","article-title":"Temporal profile of amyloid-beta (Abeta) oligomerization in an in\u00a0vivo model of Alzheimer disease. A link between Abeta and tau pathology","volume":"281","author":"Oddo","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2017.12.004_bib44","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF00296744","article-title":"Cholinesterases colocalize with sites of neurofibrillary degeneration in aged and Alzheimer's brains","volume":"87","author":"Moran","year":"1994","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biochi.2017.12.004_bib45","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetylcholinesterase accelerates assembly of amyloid-\u03b2-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme","volume":"16","author":"Inestrosa","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.biochi.2017.12.004_bib46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/jmbi.1997.1245","article-title":"Acetylcholinesterase promotes the aggregation of amyloid-\u03b2-peptide fragments by forming a complex with the growing fibrils","volume":"272","author":"Alvarez","year":"1997","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.biochi.2017.12.004_bib47","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1523\/JNEUROSCI.18-09-03213.1998","article-title":"Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils","volume":"18","author":"Alvarez","year":"1998","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.biochi.2017.12.004_bib48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0197-4580(02)00230-0","article-title":"Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex","volume":"24","author":"Rees","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biochi.2017.12.004_bib49","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neuroscience.2015.04.039","article-title":"Butyrylcholinesterase-knockout reduces brain deposition of fibrillar \u03b2-amyloid in an Alzheimer mouse model","volume":"298","author":"Reid","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.biochi.2017.12.004_bib50","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-2952(02)01514-9","article-title":"\u03b2-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies","volume":"65","author":"Bartolini","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biochi.2017.12.004_bib51","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nbd.2013.10.019","article-title":"Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition","volume":"62","author":"Baglietto-Vargas","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biochi.2017.12.004_bib52","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1750-3639.2010.00430.x","article-title":"Methylene blue reduces A\u03b2 levels and rescues early cognitive deficit by increasing proteasome activity","volume":"21","author":"Medina","year":"2011","journal-title":"Brain Pathol."},{"key":"10.1016\/j.biochi.2017.12.004_bib53","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/S0140-6736(16)31275-2","article-title":"Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial","volume":"388","author":"Gauthier","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.biochi.2017.12.004_bib54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40478-015-0204-4","article-title":"Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau","volume":"3","author":"Hochgr\u00e4fe","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.biochi.2017.12.004_bib55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FBP.0000000000000133","article-title":"Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models","volume":"26","author":"Melis","year":"2015","journal-title":"Behav. Pharmacol."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908417303346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908417303346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T07:41:10Z","timestamp":1565336470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908417303346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":55,"alternative-id":["S0300908417303346"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2017.12.004","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2017.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights reserved.","name":"copyright","label":"Copyright"}]}}